North America market for Cardiovascular Diagnostic and Monitoring Devices was worth 824.28 million in 2018 and estimated to be growing at a CAGR of 6.53%, to reach1130.82 million by 2023. Cardiovascular disease is a medical condition which affects the structure and function of organs associated with function of heart and its circulation
Cardio Vascular diseases are the primary cause of death and witnessing a high rise in prevalence. There are a large number of people being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions shifting focus towards preventative healthcare.
North America market for cardiovascular devices is majorly driven factors such as increasing number of people suffering from diabetes and obesity and growing risks related to hypertension, heart muscle weakening. Advancements in Technology have enabled portability features such as portability in performing various tests are also adding to the growth of Cardiovascular Monitoring market. However unclear reimbursement policies, stringent government regulations for product approvals and high cost of devices are some the major factors restraining the market growth.
North American market for cardiovascular diagnostic and monitoring devices is studied on the basis of product which is further segmented into ECG systems, Holter Monitors, Event Monitors, Implantable loop recorders and ECG management systems. Electrocardiographs segment is further sub segmented into Resting ECG systems and Stress ECG systems. ECG systems holds the largest share in the market and expected to maintain its strong in the market during the forecast period due to widespread availability and increasing preference for diagnostic devices in both developed and developing regions.
On the basis of geography North America market for cardiovascular diagnostic and monitoring devices market is analysed under various regions namely United States and Canada. With in North America United States is the largest market for cardiovascular diagnostic and monitoring devices and is expected to sustain its strong share due to its high awareness about available diagnosis and treatment methods among patients and physicians.
North America Cardiovascular Diagnostic and monitoring market is dominated by two companies namely Phillips healthcare and GE healthcare accounting for an approximately 50% share in 2018. Other major players covered in the report are Siemens Healthcare, Boston Scientific Corporation, St. Jude Medical, Inc., Nihon Kohden Corporation, and Welch Allyn, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 ECG Systems
5.1.1.1 Resting ECG Systems
5.1.1.2 Stress ECG Systems
5.1.2 Event Monitors
5.1.3 Holter Monitors
5.1.4 Implantable Loop Recorders
5.1.5 ECG Management Systems
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Philips Healthcare
8.3 Siemens Healthcare
8.4 Boston Scientific Corporation
8.5 St. Jude Medical, Inc
8.6 Nihon Kohden Corporation
8.7 Welch Allyn, Inc.
8.8 Spacelabs Healthcare
8.9 LivaNova PLC
8.10 Hill-Rom Holdings, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
